Trend in Hospital Lengths of Stay and Readmissions

NCT ID: NCT03107364

Last Updated: 2017-04-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-21

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Medical and surgical innovations have allowed to shorter length of hospital stay (LOS). We assume that hospitals with uncontrolled reduction in LOS may expose patients to unsafe care. At the institutional level, a dynamic analysis of LOS evolution over time could clarify the existence of a link with the risk of readmission.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trend in Hospital Lengths of Stay and Readmissions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Colorectal surgery

Patient who underwent elective colorectal surgery

Hospital stay

Intervention Type OTHER

Collection of hospital lengths of stay and readmissions

Hip fracture

Patient who underwent urgent surgical procedure for hip fracture

Hospital stay

Intervention Type OTHER

Collection of hospital lengths of stay and readmissions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hospital stay

Collection of hospital lengths of stay and readmissions

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who underwent elective colorectal surgery or urgent surgical procedure for hip fracture in French public and private hospitals from January 2014 to December 2016

Exclusion Criteria

* Age \< 18 years old
* Death during the index stay
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antoine DUCLOS, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Pôle Information Médicale Evaluation Recherche des Hospices Civils de Lyon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pôle Information Médicale Evaluation Recherche des Hospices Civils de Lyon

Lyon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Antoine DUCLOS, MD, PhD

Role: CONTACT

04 72 11 51 66 ext. +33

Stéphanie POLAZZI

Role: CONTACT

04 72 11 57 21 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Antoine DUCLOS, MD, PhD

Role: primary

04 72 11 51 66 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL17_0036

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.